Mirae Asset Global ETFs Holdings
ENTA icon

Mirae Asset Global ETFs Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164K Buy
12,974
+306
+2% +$4.1K ﹤0.01% 2453
2025
Q4 		$200K Buy
12,668
+2,962
+31% +$37.6K ﹤0.01% 2350
2025
Q3 		$116K Sell
9,706
-1,771
-15% -$14.2K ﹤0.01% 2596
2025
Q2 		$86.8K Sell
11,477
-546
-5% -$3.28K ﹤0.01% 2679
2025
Q1 		$66.4K Buy
12,023
+552
+5% +$3.41K ﹤0.01% 2782
2024
Q4 		$66K Buy
11,471
+540
+5% +$5.18K ﹤0.01% 2847
2024
Q3 		$113K Buy
10,931
+1,169
+12% +$15.3K ﹤0.01% 2658
2024
Q2 		$127K Buy
+9,762
New +$132K ﹤0.01% 2465

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ENTA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Enanta Pharmaceuticals (ENTA) stake by 2.4% in Q1 2026, buying an estimated $4.1K and bringing the position to 12,974 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

Mirae Asset Global ETFs Holdings first reported a position in ENTA in Q2 2024 and has held it in 8 quarters since. The position peaked at $200K in Q4 2025. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 12,974 shares of Enanta Pharmaceuticals worth $164K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 306 Enanta Pharmaceuticals shares in Q1 2026, an estimated $4.1K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2453 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Enanta Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Enanta Pharmaceuticals position peaked at $200K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.